Stifel analyst Andreas Heine downgraded EMS-Chemie to Hold from Buy with a price target of CHF 700, down from CHF 810. The analyst expects a weak Q4 amid destocking and sees a lack of catalysts for the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly